February 20, 2026

Looking back at life 2026: Connecting the life science ecosystem across regions

Looking back at life 2026: Connecting the life science ecosystem across regions

One week after life – the biomedical convention 2026, one thing is clear: the conference once again showed how powerful connected ecosystems are in driving biomedical innovation.

Around 500 participants from academia, startups, industry, investment and policy – mainly from the bioRN network, but with a growing number of attendees from beyond the region – made life a central platform for exchange, translation and collaboration.

Content-wise, the program ranged from synthetic biology and new platform technologies to translation and scaling, as well as dual use and societal resilience. The conference showcased not only scientific breakthroughs, but also concrete success stories from the regional and European ecosystem.
A strong signal of this growing connectivity was the presence of our partner clusters BioM Biotech Cluster Development GmbH, biomindz, nanodiag BW Zukunftscluster and BIOPRO Baden-Württemberg GmbH.

The International Investor Panel added a European perspective on the situation of founders, focusing on financing, scaling and internationalisation.

With the Young Scientists Pitch Competition, another core ambition of bioRN became visible: giving young researchers an early stage and increasing the visibility of their ideas. Congratulations to this year’s winner Markus Meier (Max-Planck Institute for Terrestrial Microbiology!

2026 is a special year for bioRN:
30 years of networking
30 years of ecosystem building
life – the biomedical convention as a visible expression of this journey.

See you back in 2027 in our vibrant life science ecosystem!
Hashtag#life2027
3rd February
Heidelberg Congress Center

Our latest News

discover more
Hummingbird Diagnostics to Present Blood-Based RNA Biomarker Data in Stage III Lung Cancer at ESMO 2026

Hummingbird Diagnostics to Present Blood-Based RNA Biomarker Data in Stage III Lung Cancer at ESMO 2026

More Information HEIDELBERG, Germany, September 30, 2026 – Hummingbird Diagnostics GmbH, a molecular diagnostics company specializing in blood-based small RNA analysis for precision oncology, today announced that data from a new collaborative study will be presented at the ESMO Congress 2026 in Madrid, Spain. Building on Hummingbird’s expertise in early cancer detection, the study explores […]

Greater Precision and Safety in Neurosurgical Procedures

Greater Precision and Safety in Neurosurgical Procedures

A new surgical system at the Department of Neurosurgery at Heidelberg University Hospital helps surgeons precisely plan procedures on the brain, spine, and skull base, monitor them during surgery, and perform them with millimeter precision. The “Robotic Surgery Suite,” which cost approximately 1.6 million euros, combines live imaging, digital navigation, and robotic assistance directly in […]

Mitochondrial Protein Complexes: A Single Amino Acid Can Jeopardize Their Stability

Mitochondrial Protein Complexes: A Single Amino Acid Can Jeopardize Their Stability

Scientists from Heidelberg and Freiburg identify the mechanism by which proteins assemble into stable complexes in mitochondria A tiny processing step has far-reaching consequences for mitochondrial function: The removal of a single amino acid determines whether new proteins can assemble into stable complexes within these cellular powerhouses. This process is carried out by a specific […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp